150 related articles for article (PubMed ID: 37697316)
21. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
22. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
Front Immunol; 2021; 12():643529. PubMed ID: 33679807
[No Abstract] [Full Text] [Related]
23. Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma.
Birnbaum DJ; Begg SKS; Finetti P; Vanderburg C; Kulkarni AS; Neyaz A; Hank T; Tai E; Deshpande V; Bertucci F; Birnbaum D; Lillemoe KD; Warshaw AL; Mino-Kenudson M; Fernandez-Del Castillo C; Ting DT; Liss AS
Clin Cancer Res; 2021 Apr; 27(8):2314-2325. PubMed ID: 33547202
[TBL] [Abstract][Full Text] [Related]
24. Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection.
Drifka CR; Loeffler AG; Mathewson K; Keikhosravi A; Eickhoff JC; Liu Y; Weber SM; Kao WJ; Eliceiri KW
Oncotarget; 2016 Nov; 7(46):76197-76213. PubMed ID: 27776346
[TBL] [Abstract][Full Text] [Related]
25. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB
Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.
Gebauer F; Tachezy M; Effenberger K; von Loga K; Zander H; Marx A; Kaifi JT; Sauter G; Izbicki JR; Bockhorn M
J Surg Oncol; 2011 Aug; 104(2):140-5. PubMed ID: 21520098
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA DLEU1 aggravates pancreatic ductal adenocarcinoma carcinogenesis via the miR-381/CXCR4 axis.
Gao S; Cai Y; Zhang H; Hu F; Hou L; Xu Q
J Cell Physiol; 2019 May; 234(5):6746-6757. PubMed ID: 30382579
[TBL] [Abstract][Full Text] [Related]
28. The WNT5A/ROR2 signaling pathway in pancreatic ductal adenocarcinoma (PDAC).
Remtisch L; Wiltberger G; Schierle K; Yousef M; Thieme R; Jansen Winkeln B; Wittekind C; Gockel I; Lyros O
J BUON; 2021; 26(4):1595-1606. PubMed ID: 34565024
[TBL] [Abstract][Full Text] [Related]
29. Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer.
Blair AB; Kim VM; Muth ST; Saung MT; Lokker N; Blouw B; Armstrong TD; Jaffee EM; Tsujikawa T; Coussens LM; He J; Burkhart RA; Wolfgang CL; Zheng L
Clin Cancer Res; 2019 Sep; 25(17):5351-5363. PubMed ID: 31186314
[TBL] [Abstract][Full Text] [Related]
30. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression.
Koshiba T; Hosotani R; Miyamoto Y; Ida J; Tsuji S; Nakajima S; Kawaguchi M; Kobayashi H; Doi R; Hori T; Fujii N; Imamura M
Clin Cancer Res; 2000 Sep; 6(9):3530-5. PubMed ID: 10999740
[TBL] [Abstract][Full Text] [Related]
31. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
[No Abstract] [Full Text] [Related]
32. Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.
Ijichi H; Chytil A; Gorska AE; Aakre ME; Bierie B; Tada M; Mohri D; Miyabayashi K; Asaoka Y; Maeda S; Ikenoue T; Tateishi K; Wright CV; Koike K; Omata M; Moses HL
J Clin Invest; 2011 Oct; 121(10):4106-17. PubMed ID: 21926469
[TBL] [Abstract][Full Text] [Related]
33. Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarcinoma.
Yan B; Liu L; Zhao L; Hinz U; Luo Y; An X; Gladkich J; de la Torre C; Huang Z; Schrapel D; Gross W; Fortunato F; Schaefer M; Gaida MM; Herr I
Matrix Biol; 2022 Dec; 114():84-107. PubMed ID: 36375776
[TBL] [Abstract][Full Text] [Related]
34. Interaction of immune checkpoint PD-1 and chemokine receptor 4 (CXCR4) promotes a malignant phenotype in pancreatic cancer cells.
Harper MM; Lin M; Cavnar MJ; Pandalai PK; Patel RA; Gao M; Kim J
PLoS One; 2022; 17(7):e0270832. PubMed ID: 35797269
[TBL] [Abstract][Full Text] [Related]
35. Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma.
Hu D; Ansari D; Zhou Q; Sasor A; Said Hilmersson K; Andersson R
World J Surg Oncol; 2019 Feb; 17(1):29. PubMed ID: 30736807
[TBL] [Abstract][Full Text] [Related]
36. CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer.
Adachi K; Sakurai Y; Ichinoe M; Tadehara M; Tamaki A; Kesen Y; Kato T; Mii S; Enomoto A; Takahashi M; Koizumi W; Murakumo Y
Virchows Arch; 2022 Apr; 480(4):819-829. PubMed ID: 34762199
[TBL] [Abstract][Full Text] [Related]
37. [Epithelial-stromal interactions in pancreatic adenocarcinoma: the role of stroma in disease progression].
Kuznetsova AV; Popova OP; Astakhov DA; Ivanov YV; Panchenkov DN; Ivanov AA
Arkh Patol; 2022; 84(5):65-70. PubMed ID: 36178225
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma.
Korpela T; Ristimäki A; Udd M; Vuorela T; Mustonen H; Haglund C; Kylänpää L; Seppänen H
BMC Cancer; 2022 Jan; 22(1):23. PubMed ID: 34980011
[TBL] [Abstract][Full Text] [Related]
39. Stroma composition and proliferative activity are related to therapy response in neoadjuvant treated pancreatic ductal adenocarcinoma.
Haeberle L; Cacciato Insilla A; Kapp AC; Steiger K; Schlitter AM; Konukiewitz B; Demir IE; Friess H; Esposito I
Histol Histopathol; 2021 Jul; 36(7):733-742. PubMed ID: 33769550
[TBL] [Abstract][Full Text] [Related]
40. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
